Literature DB >> 10679548

Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin.

R J Cameron1, J Kolbe, M L Wilsher, N Lambie.   

Abstract

The spectrum of nitrofurantoin lung injury continues to widen. The case histories are presented of two patients who developed lung disease associated with the use of nitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia (BOOP), a rare but recognised form of drug induced injury. The two middle aged women presented with respiratory symptoms after prolonged treatment with nitrofurantoin. Both had impaired lung function and abnormal computed tomographic scans, and their condition improved when nitrofurantoin was withdrawn and corticosteroid treatment commenced. The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of nitrofurantoin induced BOOP. We suggest that the previous classification of nitrofurantoin induced lung injury into "acute" and "chronic" injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679548      PMCID: PMC1745713          DOI: 10.1136/thorax.55.3.249

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Nitrofurantoin-induced pulmonary reaction involving respiratory symptoms: case report.

Authors:  Zahra Kanji; Victoria C H Su; Raj Mainra
Journal:  Can J Hosp Pharm       Date:  2011-09

2.  Nitrofurantoin-induced interstitial pneumonitis: albeit rare, should not be missed.

Authors:  Haamid Syed; Ghassan Bachuwa; Sunil Upadhaya; Firas Abed
Journal:  BMJ Case Rep       Date:  2016-02-24

Review 3.  Organizing pneumonia: a kaleidoscope of concepts and morphologies.

Authors:  Benjamin J Roberton; David M Hansell
Journal:  Eur Radiol       Date:  2011-07-10       Impact factor: 5.315

Review 4.  Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.

Authors:  Fumikazu Sakai; Takeshi Johkoh; Masahiko Kusumoto; Hiroaki Arakawa; Masahiro Takahashi
Journal:  Int J Clin Oncol       Date:  2012-11-10       Impact factor: 3.402

5.  Nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia: report of a case.

Authors:  Mark E Fenton; Rani Kanthan; Donald W Cockcroft
Journal:  Can Respir J       Date:  2008-09       Impact factor: 2.409

6.  Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review.

Authors:  Sara Al-Ghanem; Hamdan Al-Jahdali; Hanaa Bamefleh; Ali Nawaz Khan
Journal:  Ann Thorac Med       Date:  2008-04       Impact factor: 2.219

7.  Relapsing nitrofurantoin-induced pneumonitis.

Authors:  Richard D Turner; Chris M Barber
Journal:  Respir Med Case Rep       Date:  2011-12-12

8.  Nitrofurantoin Toxicity: A Near Case of Mistaken Identity.

Authors:  Jeffrey A Miskoff; Moiuz Chaudhri
Journal:  Cureus       Date:  2018-09-17

Review 9.  Cryptogenic organizing pneumonia.

Authors:  Jean-François Cordier
Journal:  Clin Chest Med       Date:  2004-12       Impact factor: 2.878

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.